In this study, the levels of MIF, GP73, PIVKA-II, AFP-L3 and AFP in serum were examined, aiming to investigate its application value in diagnosing primary liver cancer and provide a new direction for the clinical diagnosis and treatment of primary liver cancer. This evidence concerns the gene MIF and liver cancer.